Featured
-
-
Article |
LYP inhibits T-cell activation when dissociated from CSK
The protein phosphatase LYP is known to regulate signaling in the immune system, but the regulatory mechanisms controlling LYP itself are less clear. Exploration of spatiotemporal dynamics and application of a newly identified chemical inhibitor now define a role for the kinase CSK in dialing down LYP activity.
- Torkel Vang
- , Wallace H Liu
- & Lutz Tautz
-
News & Views |
Taming the APC
The activity of the anaphase-promoting complex is regulated by the autoubiquitination of Cdc20. How this autoubiquitination is regulated remains an open question. The pharmacological inhibitor TAME now provides insight into this regulation.
- Ian T Foe
- & David P Toczyski
-
Article |
Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles
DNA-templated macrocycles bind the ATP binding pocket of Src kinase, locking it into an inactive conformation. These small-molecule inhibitors compete with both ATP and substrate for binding and inhibit the T338I gatekeeper mutant version of Src.
- George Georghiou
- , Ralph E Kleiner
- & Markus A Seeliger
-
News & Views |
IP4 is an epigenetic coregulator
Inositol tetraphosphate is required for both the incorporation of the histone deacetylase HDAC3 into a repressive complex and its enzymatic activity.
- Tatiana G Kutateladze
-
Article |
Small-molecule–induced DNA damage identifies alternative DNA structures in human genes
Identifying DNA sequences that adopt alternative structures within the context of genomic DNA presents a major challenge. Pyridostatin, a G-quadruplex–specific chemical probe, was shown to induce DNA damage at specific genomic sites, including the proto-oncogene SRC, leading to cell cycle arrest in human cancer cells.
- Raphaël Rodriguez
- , Kyle M Miller
- & Stephen P Jackson
-
Article |
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
MLL fusion genes often encode leukemogenic proteins that depend on interaction with menin, a component of the MLL SET1-like histone methyltransferase complex. MI-2 and MI-3 are the first small molecules that can block menin–MLL fusion protein interaction and their oncogenic effects in cells.
- Jolanta Grembecka
- , Shihan He
- & Tomasz Cierpicki
-
-
Article |
Chemical chaperones assist intracellular folding to buffer mutational variations
Osmolytes act as chemical chaperones capable of directly assisting the folding of destabilizing mutations in proteins in vivo, with different osmolytes having distinct targets and thereby increasing the level of genetic variability.
- Anannya Bandyopadhyay
- , Kanika Saxena
- & Kausik Chakraborty
-
Article |
Oxysterols are allosteric activators of the oncoprotein Smoothened
20(S)-hydroxycholesterol binds to Smo at a site distinct from cyclopamine and activates signaling via an allosteric mechanism. A new alkyne oxysterol analog selectively captures Smo from membrane extracts and provides a new method for detecting protein-sterol interactions.
- Sigrid Nachtergaele
- , Laurel K Mydock
- & Rajat Rohatgi
-
Article |
Timing facilitated site transfer of an enzyme on DNA
DNA repair proteins require efficient pathways to search for DNA damage lesions within a large genome. Kinetic trapping experiments define the rates of human uracil DNA glycosylase hopping and sliding along damaged DNA substrates and highlight the role of the phosphodiester backbone in DNA sliding.
- Joseph D Schonhoft
- & James T Stivers
-
Article |
Small-molecule proteostasis regulators for protein conformational diseases
Screens of large compound libraries identify new small–molecule proteostasis regulators that, by enhancing the activity of the heat shock response factor HSF–1 and by activating other components of the proteostasis network, such as the antioxidant response or the unfolded protein response pathways, restore protein folding in multiple models of protein conformational diseases.
- Barbara Calamini
- , Maria Catarina Silva
- & Richard I Morimoto
-
-
Article |
Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
An orcein-related small molecule can drive polymerization of amyloid-β, implicated in Alzheimer's disease, without remodeling oligomeric or fibril forms but by stabilizing a seeding-competent protofilament state and shortening the lag phase of spontaneous polymerization.
- Jan Bieschke
- , Martin Herbst
- & Erich E Wanker
-
Brief Communication |
Dafadine inhibits DAF-9 to promote dauer formation and longevity of Caenorhabditis elegans
Dafadines, identified in a screen for compounds that induce the dauer phenotype in C. elegans, also promote longevity in adult worms, with both phenotypes occurring through inhibition of DAF-9, a cytochrome P450 involved in the insulin signaling pathway.
- Genna M Luciani
- , Lilia Magomedova
- & Peter J Roy
-
Article |
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Rapid reversible inhibitors of the oxygenation activity of COX-2, including ibuprofen and naproxen, selectively inhibit the enzyme with endocannabinoid 2-AG substrates but not with arachidonic acid, and this substrate-selective inhibition may be important for the analgesic activity of the drugs.
- Kelsey C Duggan
- , Daniel J Hermanson
- & Lawrence J Marnett
-
Article |
Chemical inhibitors of monogalactosyldiacylglycerol synthases in Arabidopsis thaliana
Mono- and digalactosyldiacylglycerols (MGDGs and DGDGs) are glycolipids that are central to plant metabolism and photosynthetic membrane biogenesis. Galvestine-1, a small molecule inhibitor of MGDG synthases that was identified in a high-throughput chemical screen in Arabidopsis thaliana, reveals a new role for these galactolipids in pollen-tube development.
- Cyrille Y Botté
- , Michael Deligny
- & Eric Maréchal
-
Article |
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
The inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes. Affinity purification using PU-H71 reveals cancer-specific protein networks in chronic myeloid leukemia and that the abundance of tumor-specific Hsp90 clients in cells can predict sensitivity to Hsp90 inhibitors.
- Kamalika Moulick
- , James H Ahn
- & Gabriela Chiosis
-
Article |
Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor
A screen for compounds that alleviate the inhibitory effect of influenza NS1 on host gene expression and suppress viral toxicity found naphthalimides that could upregulate REDD1, an mTORC1 inhibitor, revealing that viruses inhibit REDD1 to activate the mTORC1 pathway.
- Miguel A Mata
- , Neal Satterly
- & Beatriz M A Fontoura
-
Article |
Small-molecule displacement of a cryptic degron causes conditional protein degradation
The synthetic compound Shield-1 can already be used to protect designed fusion proteins from degradation. The development of a new protein domain that is degraded upon addition of Shield-1 expands the compound's utility in controlling protein function and allows the simultaneous degradation and stabilization of different constructs.
- Kimberly M Bonger
- , Ling-chun Chen
- & Thomas J Wandless
-
Article |
Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins
A search through hydrophobic chemical space identifies an adamantane tag that targets dehalogenase fusion proteins for degradation, as demonstrated for both cytosolic and transmembrane proteins; and in zebrafish and mice. This molecule provides a new tool to study protein function with precise control.
- Taavi K Neklesa
- , Hyun Seop Tae
- & Craig M Crews
-
Article |
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble
Protein-focused lead-identification strategies may be limited in their ability to identify small molecules that bind to cellular RNAs. Docking small molecules against the structural ensemble substantially improves the docking accuracy of TAR and has led to the identification of six new TAR binders, one of which inhibits HIV-1 replication.
- Andrew C Stelzer
- , Aaron T Frank
- & Hashim M Al-Hashimi
-
Article |
A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis
A target-identification strategy based on the yeast three-hybrid system and the SNAP-tag labeling technique identifies new targets for three small-molecule drugs and helps identify a new mechanism for the activity of the anti-inflammatory drug sulfasalazine involving inhibition of sepiapterin reductase.
- Christopher Chidley
- , Hirohito Haruki
- & Kai Johnsson
-
Brief Communication |
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
A specific and potent inhibitor of the DNA damage response kinase ATR can exploit synthetic lethality between ATR and the related kinase ATM to sensitize ATM-defective cancer cells to ionizing radiation and DNA-damaging drugs.
- Philip M Reaper
- , Matthew R Griffiths
- & John R Pollard
-
News & Views |
Low-fat worms on drugs
High-throughput screening in Caenorhabditis elegans identified a compound that distinctly regulates fat storage and feeding, highlighting new players in energy homeostasis.
- Bridget K Wagner
-
Article |
A whole-organism screen identifies new regulators of fat storage
A screen for compounds that alter fat content in C. elegans identifies a novel agonist of an AMP-activated kinase pathway that reduces fat storage as well as implicates the transcription factor K08F8.2 as a regulator of fat metabolism.
- George A Lemieux
- , Jason Liu
- & Zena Werb
-
Brief Communication |
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
A potent and selective inhibitor of the kinase LRRK2 identified using an in vitro ATP-site competition binding assay also inhibits the G2019S mutant, implicated in Parkinson's disease, as well as the regulatory feedback loop where LRRK2 is phosphorylated and binds 14-3-3 protein.
- Xianming Deng
- , Nicolas Dzamko
- & Nathanael S Gray
-
News & Views |
Knock, Nox—ROS there?
The development of small-molecule probes for use in neural stem cells demonstrates the importance of endogenous ROS signaling in regulating in vivo phenotypes.
- Kate S Carroll
-
Article |
A mammalian functional-genetic approach to characterizing cancer therapeutics
Identifying the cellular targets of small molecules remains a central challenge of chemical biology. The application of an RNAi-based functional genomics approach permitted the clustering of drugs with related targets by 'shRNA signatures', which served as a basis set to assign modes of action to compounds with unknown targets.
- Hai Jiang
- , Justin R Pritchard
- & Michael T Hemann
-
Commentary |
Grand Challenge Commentary: Chemical transdifferentiation and regenerative medicine
The ability to alter cell identity with small molecules represents a powerful approach to restore biological function lost because of cellular deficiency. Developing this capability through advances in chemical biology could have an enormous impact on human health.
- Bridget K Wagner
-
Commentary |
Grand Challenge Commentary: RNA epigenetics?
Post-transcriptional RNA modifications can be dynamic and might have functions beyond fine-tuning the structure and function of RNA. Understanding these RNA modification pathways and their functions may allow researchers to identify new layers of gene regulation at the RNA level.
- Chuan He
-
Commentary |
Grand Challenge Commentary: Beyond discovery: probes that see, grab and poke
Chemical biology is now able to discover molecules that manipulate virtually any biological target or process. It remains a grand challenge to leverage these molecules into useful probes that can be used to address unsolved problems in biology.
- Joshua A Kritzer
-
Commentary |
Grand Challenge Commentary: Synthetic immunology to engineer human immunity
Rationally designing new strategies to control the human immune response stands as a key challenge for the scientific community. Chemical biologists have the opportunity to address specific issues in this area that have important implications for both basic science and clinical medicine.
- David A Spiegel
-
Commentary |
Grand Challenge Commentary: Accessing new chemical space for 'undruggable' targets
The synthesis and biological annotation of small molecules from underexplored chemical space will play a central role in the development of drugs for challenging targets currently being identified in frontier areas of biological research such as human genetics.
- Sivaraman Dandapani
- & Lisa A Marcaurelle
-
Article |
Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins
Expression of a Huntington's-disease variant of huntingtin protein causes accumulation of the chaperone protein disulfide isomerase. This protein is the target of compounds obtained from screening for those that can alleviate cell death promoted by the mutant huntingtin, and represents a new connection between protein misfolding and cell death.
- Benjamin G Hoffstrom
- , Anna Kaplan
- & Brent R Stockwell
-
Brief Communication |
Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer
The antiviral S-acyl-2-mercaptobenzamide thioester ejects an essential coordinated zinc ion from and induces aggregation and dysfunction of the HIV-1 nucleocapsid protein NCp7 via repetitive intracellular enzymatic acyl transfers, dependent on acetyl-CoA.
- Lisa M Miller Jenkins
- , David E Ott
- & Ettore Appella
-
Article |
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
A Xenopus laevis two-reporter screen identifies the antihelminthic drug pyrvinium as an inhibitor of the Wnt/β-catenin signaling pathway that works by activating CK1α, which is likely working at the level of Pygopus, a core transcriptional component of the Wnt pathway.
- Curtis A Thorne
- , Alison J Hanson
- & Ethan Lee
-
Article |
A small-molecule screen identifies new functions for the plant hormone strigolactone
Secretion of strigolactone from plant roots mediates mutualistic fungal interactions but also facilitates parasitic plant invasion. A screen in Arabidopsis thaliana has identified compounds that perturb strigolactone levels and link this hormone to light signaling pathways in host plants.
- Yuichiro Tsuchiya
- , Danielle Vidaurre
- & Peter McCourt
-
Article |
A small-molecule inhibitor shows that pirin regulates migration of melanoma cells
A chemical array screen identifies a small-molecule inhibitor of pirin that inhibits its interaction with the oncoprotein Bcl3 and decreases the expression of the tumor mobility protein SNAI2. As a result, the compound perturbs the migration of melanoma cells that have high pirin expression levels.
- Isao Miyazaki
- , Siro Simizu
- & Hiroyuki Osada
-
Article |
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
Chemical screening in C. elegans is limited by the relatively poor target accessibility of small molecules. A systematic survey of drug-like small molecule accumulation and metabolism in C. elegans was used to create a computational tool for preselecting compounds likely to effectively perturb worms.
- Andrew R Burns
- , Iain M Wallace
- & Peter J Roy
-
Article |
Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis
A new pathway screen for small molecules that suppress or enhance an RNAi phenotype in Drosophila cells was used to identify a collection of compounds that perturb different steps in the Rho pathway.
- Adam B Castoreno
- , Yegor Smurnyy
- & Ulrike S Eggert
-
Article |
Small-molecule inhibition of APT1 affects Ras localization and signaling
Reversible palmitoylation controls the localization and signaling of Ras. Development of a potent and specific small molecule inhibitor of the thioesterase APT1 reveals that this enzyme depalmitoylates Ras in cells. Inhibition of APT1 led to redistribution and altered activity of HRas, NRas and an oncogenic mutant Ras.
- Frank J Dekker
- , Oliver Rocks
- & Herbert Waldmann
-
Article |
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function
- Nicholas Kwiatkowski
- , Nannette Jelluma
- & Nathanael S Gray
-
News & Views |
An upfront investment
Organic synthesis plays a leading role in the discovery of small molecules for the exploration of biological systems. Therefore, the development of efficient strategies for the preparation of these molecules is a necessary aspect of the small-molecule approach to chemical biology.
- Damian W Young
-
-
Article |
Rapid behavior-based identification of neuroactive small molecules in the zebrafish
Despite the need for new psychoactive drugs, there are few robust approaches for discovering novel neuroactive molecules. Development of a behavior-based high-throughput screen in zebrafish led to the discovery of molecules with neurological effects. Translating the complex behavioral phenotypes elicited by compounds into a simple barcode enabled identification of their mechanism of action.
- David Kokel
- , Jennifer Bryan
- & Randall T Peterson